Association of dopamine receptor gene polymorphism and psychological personality traits in liability for opioid addiction

Bosnian Journal of Basic Medical Sciences

Volumn 13, Issue 3, 2013, Pages 158-162

  Mehić Basara, Nermana ^a   Oruč, Lilijana ^b   Kapur Pojskić, Lejla ^c   Ramić, Jasmin ^c  

^a Public Institute for Alcoholism and Substance Abuse Sarajevo   (Bosnia and Herzegovina)

^b UNIVERSITY OF SARAJEVO   (Bosnia and Herzegovina)

^c Institute for Genetic Engineering and Biotechnology   (Bosnia and Herzegovina)

Author keywords

EPQ; Genetic association; Genetics; Heroin; MMT; Opioid addiction; Pas psychoactive substance; Personality traits

Indexed keywords

DIAMORPHINE; DOPAMINE 2 RECEPTOR; DRD2 PROTEIN, HUMAN; METHADONE;

ARTICLE; BOSNIA AND HERZEGOVINA; CASE CONTROL STUDY; FEMALE; GENETIC POLYMORPHISM; GENETIC PREDISPOSITION; GENETICS; GENOTYPE; HUMAN; MALE; OPIATE ADDICTION; PERSONALITY; PROSPECTIVE STUDY; PSYCHOLOGICAL ASPECT; QUESTIONNAIRE; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; RISK FACTOR;

BOSNIA-HERZEGOVINA; CASE-CONTROL STUDIES; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HEROIN; HUMANS; MALE; METHADONE; OPIOID-RELATED DISORDERS; PERSONALITY; POLYMORPHISM, GENETIC; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; PROSPECTIVE STUDIES; QUESTIONNAIRES; RECEPTORS, DOPAMINE D2; RISK FACTORS;

EID: 84883639525     PISSN: 15128601     EISSN: 18404812     Source Type: Journal    
DOI: 10.17305/bjbms.2013.2355     Document Type: Article

References (25)

1. Mehić-Basara N, Hasečić H, Pokrajac M, Selman S. Vodič za prim-jenu metadona kod ovisnika o opijatima, Ministarstvo zdravstva Kantona Sarajevo. JU Zavod za alkoholizam i druge toksikomanije Kantona Sarajevo, Sarajevo, 2007 (in Bosnian).
2. Oruc L. Psihofarmakoloski mehanizmi djelovanja kod zloupotrebe psihoaktivnih supstanci. In: Ceric I, Mehic - Basara N, Oruc L, Salihovic H (eds). Zloupotreba psihaktivnih supstanci i lijekova, Medicinski fakultet univerziteta u Sarajevu, 2007, Sarajevo, pp. 251-301 (in Bosnian).
3. Lachman H. An overview of the genetics of substance use disorders. Current Psychiatry Reports. 2006; 8(2): 133-143.
4. Merikangas KR, Stolar M, Stevens DE, Goulet J, Preisig MA, Fen-ton B. Familial transmission of substance use disorders. Arch Gen Psychiatry. 1998; 55:973-979.
5. Miller SA, Dykes DD, Polesky HF. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 1988; 16(3): 1215.
6. Grandy D, Litt M, Allen L, Bunzow J.R, Marchionni M, Makam H, et al. The human dopamine D2 receptor gene is located on chromosome 11 at q22-q23 and identifies a TaqI RFLP. Am J Hum Genet 1989; 45:778-785.
7. 158Met, MAOA-LPR, DAT-VNTR and 5-HTTVNTR gene polymorphisms and antisocial personality disorder in male heroin-dependent Chinese subjects. Prog Neuropsychopharmacol Biol Psychiatry. 2012; 36(2): 282-289.
8. Le Bon O, Basiaux P, Streel E, Tecco J, Hanak C, Dupont S, et al. Personality profile and drug of choice; a multivariate analysis using Cloninger's TCI on heroin addicts, alcoholics, and a random population group. Drug Alcohol Depend 2004; 73(2): 175-182.
9. Trémeau F, Darreye A, Leroy B, Renckly V, Ertlé S, Macher J, et al. Personality changes in opioid-dependent subjects in a methadone maintenance treatment program, L'encéphale, 2003; 29(4 Pt 1): 285-292.
10. Yeh Y, Lu R, Tao P, Shih M, Lin W, Huang S. Neither single-marker nor haplotype analyses support an association between the dopamine transporter gene and heroin dependence in Han Chinese. Genes Brain Behav 2010; 9(6): 638-647.
11. Yeh Y, Lu R, Tao P, Shih M, Huang S. A possible association of the norepinephrine transporter gene in the development of heroin dependence in Han Chinese. Pharmacogenet Genomics; 2011, 21(4): 197-205.
12. Glatt SJ, Su JA, Zhu SC, Zhang R, Zhang B, Li J et al. Genome-wide linkage analysis of heroin dependence in Han Chinese: results from wave one of a multi-stage study. Am J Med Genet B Neuropsychi-atr Genet. 2006;141B(6):648-652.
13. Glatt S, Lasky-Su J, Zhu S, Zhang R, Zhang B, Tsuang M, et al. Genome-wide linkage analysis of heroin dependence in Han Chinese: results from Wave Two of a multi-stage study. Drug Alcohol Depend 2008; 98(1-2): 30-34.
14. Hou QF, Li SB. Potential association of DRD2 and DAT1 genetic variation with heroin dependence. Neurosci Lett. 2009; 464:127-130.
15. Perez de los Cobos J, Baiget M, Trujols J, Sinol N, Volpini V, Banuls E, Calafell F, Luquero E, del Rio E, Alvarez E. Allelic and genotypic associations of DRD2 TaqI A polymorphism with heroin dependence in Spanish subjects: a case control study. Behav Brain Funct. 2007; 3:25.
16. Gardner EL. Brain-Reward Mechanisms. In: Substance Abuse a Comprehensice textbook, Fourth edition. Lippicott Williams and Wilkins, Philadelphia, 2004; 48-78.
17. Blum K, Noble EP, Sheridan PJ, Montgomery A, Ritchie T, Jaga-deeswaran P et al. Allelic association of human dopamine D2 receptor gene in alcoholism. JAMA 1990; 263(15):2055-2060.
18. Gelernter J, OMalley S, Risch N, Kranzler H, Krystal J, Merikangas K. No association between an allele at the D2 dopamine receptor gene (DRD2) and alcoholism. JAMA 1991; 266:1801-1807.
19. Noble EP. Addiction and its reward process through polymorphisms of the D2 dopamine receptor gene: a review. Eur Psychiatry. 2000;15(2):79-89.
20. Noble EP. D2 dopamine receptor gene in psychiatric and neurologic disorders and its phenotypes. Am J Med Genet B Neuropsy-chiatr Genet. 2003;116B(1):103-125.
21. Noble E.P, Blum K, Ritchie T, Montgomery A, Sheridan P.J, Allelic associa-tion of the D2 dopamine receptor gene with receptor-binding characteristics in alcoholism, Arch Gen Psychiatry 1991; 48: 648-654.
22. Thompson J, Thomas N, Singleton A, Piggott M, Lloyd S, Perry EK et al. D2 dopamine receptor gene (DRD2) Taqi A polymorphism: reduced dopamine D2 receptor binding in the human striatum associated with the A1 allele. Pharmacogenetics 1997; 7:479-484.
23. Young RM, Lawford B.R, Nutting A, Noble E.P, Advances in molecular genetics and the prevention and treatment of substance misuse: implications of associ-ation studies of the A1 allele of the D2 dopamine receptor gene, Addict Behav 2004; 29:1275-1294.
24. Darke S, Ross J, Williamson A, Mills K, Havard A, Teesson M. Borderline personality disorder and persistently elevated levels of risk in 36-month outcomes for the treatment of heroin dependence. Addiction, 2007; 102(7): 1140-1146.
25. Xu K, Lichtermann D, Lipsky RH, et al: Association of specific hap-lotypes of D2 dopamine receptor gene with vulnerability to heroin dependence in 2 distinct populations. Arch Gen Psychiatry, 2004; 61:597-606.